25
Participants
Start Date
May 16, 2012
Primary Completion Date
November 17, 2023
Study Completion Date
November 17, 2023
nonacog beta pegol
A single dose of 40 U/kg will be administered intravenously, i.v. (into the vein) once weekly.
National Taiwan University Children's Hospital, Taipei
Mount Sinai Medical Center, New York
Maimonides Medical Center, Brooklyn
Children's Hosptl Philadelphia, Philadelphia
Istituto di Medicina Int. A. Bianchi Bonomi Univ. Milano, Milan
Medizinische Hochschule Hannover - Pädiatrische Hämato-, Onko- und Hämostasiologie, Hanover
Vanderbilt Hemostasis Thrombosis Clinic, Nashville
National Blood Centre, Kuala Lumpur
Children's Hospitals And Clinics Of Minnesota, Minneapolis
Children's Medical Center_Dallas, Dallas
The Hospital for Sick Children, Toronto
St. Marianna University School of Medicine Hospital_Pediatrics, Kanagawa
Shizuoka Children's Hospital, Hematology-Oncology, Shizuoka
Ogikubo Hospital_Pediatries & Blood, Tokyo
Basingstoke & North Hampshire Hospital - Centre for Haemophilia, Haemostasis and Thrombosis, Basingstoke
Leicester Royal Infirmary - Haemostasis & Thrombosis Unit, Leicester
Leicester Royal Infirmary, Leicester
St Thomas' Hospital - Haemostasis and Thrombosis Centre, London
St Thomas' Hospital, London
John Radcliffe Hospital, Oxford
Lead Sponsor
Novo Nordisk A/S
INDUSTRY